Boiron SA Cash Flow Conversion Efficiency

Latest as of December 2025: 0.070x

Boiron SA cash flow conversion efficiency. Based on the latest financial reports, Boiron SA (BOI) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€27.52 Million ≈ $32.17 Million USD) by net assets (€392.78 Million ≈ $459.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Boiron SA (2001–2025)

Cash flow conversion efficiency of Boiron SA from 2001 to 2025. This chart illustrates how Boiron SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Boiron SA (BOI) stock price for real-time trading data and today's change.

Boiron SA Cash Flow Conversion Ratio Explained

Boiron SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Boiron SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boiron SA ranked by their cash flow conversion efficiency. Also see Boiron SA stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Choil Aluminum
KO:018470
-0.095x
Jiaxing ZMAX Optech Co. Ltd. A
SHG:688307
N/A
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
0.027x
Samhi Hotels Limited
NSE:SAMHI
0.090x
TrueLight
TWO:3234
-0.033x
Zota Health Care LImited
NSE:ZOTA
-0.157x
Suzhou Kelida Bldg &
SHG:603828
0.085x
Dare Technology Co Ltd
SHE:000910
0.003x

Annual Cash Flow Conversion Efficiency for Boiron SA (2001–2025)

The table below shows the annual cash flow conversion efficiency of Boiron SA from 2001 to 2025. Review BOI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €392.78 Million
≈ $459.20 Million
€53.24 Million
≈ $62.24 Million
0.136x +29.67%
2024-12-31 €378.18 Million
≈ $442.14 Million
€39.53 Million
≈ $46.22 Million
0.105x -10.04%
2023-12-31 €391.50 Million
≈ $457.70 Million
€45.49 Million
≈ $53.18 Million
0.116x +10.35%
2022-12-31 €557.35 Million
≈ $651.60 Million
€58.69 Million
≈ $68.61 Million
0.105x +68.07%
2021-12-31 €531.77 Million
≈ $621.70 Million
€33.32 Million
≈ $38.95 Million
0.063x -53.27%
2020-12-31 €509.17 Million
≈ $595.27 Million
€68.27 Million
≈ $79.81 Million
0.134x +33.25%
2019-12-31 €505.46 Million
≈ $590.94 Million
€50.86 Million
≈ $59.46 Million
0.101x -41.95%
2018-12-31 €486.04 Million
≈ $568.24 Million
€84.25 Million
≈ $98.50 Million
0.173x -14.36%
2017-12-31 €517.49 Million
≈ $605.00 Million
€104.75 Million
≈ $122.46 Million
0.202x -13.69%
2016-12-31 €469.60 Million
≈ $549.01 Million
€110.13 Million
≈ $128.75 Million
0.235x -5.42%
2015-12-31 €416.04 Million
≈ $486.40 Million
€103.16 Million
≈ $120.61 Million
0.248x -2.04%
2014-12-31 €379.88 Million
≈ $444.12 Million
€96.16 Million
≈ $112.42 Million
0.253x -7.32%
2013-12-31 €391.86 Million
≈ $458.12 Million
€107.02 Million
≈ $125.11 Million
0.273x +9.17%
2012-12-31 €354.16 Million
≈ $414.05 Million
€88.59 Million
≈ $103.58 Million
0.250x +56.78%
2011-12-31 €368.65 Million
≈ $430.99 Million
€58.82 Million
≈ $68.77 Million
0.160x +6.24%
2010-12-31 €343.84 Million
≈ $401.99 Million
€51.64 Million
≈ $60.37 Million
0.150x -41.34%
2009-12-31 €313.28 Million
≈ $366.25 Million
€80.20 Million
≈ $93.76 Million
0.256x +6.15%
2008-12-31 €271.49 Million
≈ $317.40 Million
€65.48 Million
≈ $76.55 Million
0.241x +7.40%
2007-12-31 €249.94 Million
≈ $292.21 Million
€56.13 Million
≈ $65.62 Million
0.225x +33.97%
2006-12-31 €230.09 Million
≈ $268.99 Million
€38.57 Million
≈ $45.09 Million
0.168x -7.68%
2005-12-31 €229.88 Million
≈ $268.75 Million
€41.74 Million
≈ $48.80 Million
0.182x -23.95%
2004-12-31 €144.09 Million
≈ $168.46 Million
€34.40 Million
≈ $40.22 Million
0.239x -2.79%
2003-12-31 €149.53 Million
≈ $174.82 Million
€36.73 Million
≈ $42.94 Million
0.246x -4.17%
2002-12-31 €134.47 Million
≈ $157.20 Million
€34.46 Million
≈ $40.29 Million
0.256x -8.21%
2001-12-31 €119.17 Million
≈ $139.32 Million
€33.27 Million
≈ $38.90 Million
0.279x --

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic
Market Cap
$403.94 Million
€345.51 Million EUR
Market Cap Rank
#12984 Global
#199 in France
Share Price
€19.90
Change (1 day)
+2.05%
52-Week Range
€16.90 - €31.70
All Time High
€59.48
About

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more